A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age
- Study Title
- A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age
- Teva Identifier
- TV46046-WH-10159
- ClinicalTrials.gov Identifier
- NCT04682353
- Study Status
- Completed
- Trial Condition(s)
- Contraception
- Interventions
- Drug: TV-46046|Drug: Depo-subQ Provera
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female
- Age group
- Adult
- Age Range
- 18 Years to 45 Years
- Trial Duration
- December 14, 2020 - January 12, 2023
- Phase
- Phase 1